Pharvaris N.V.
NASDAQ · us_market
No AI insight generated yet for this ticker.
Pharvaris N.V., a late-stage biopharmaceutical company, focuses on the development and commercialization of therapies for rare diseases with unmet needs covering angioedema and other bradykinin-mediated diseases. The company develops deucrictibant, a small molecule bradykinin B2-receptor antagonist to treat attacks due to bradykinin-mediated angioedema, including hereditary angioedema (HAE) and acquired angioedema due to C1-inhibitor deficiency (AAE-C1INH), which is in phase 3, as well as in phase 3 trials for treatment and prophylaxis of HAE attacks; and extended-release tablet and immediate-release capsule formulation of deucrictibant. Pharvaris N.V. was incorporated in 2015 and is headquartered in Zug, Switzerland.
| Fund | Style | Shares | Value | % of Port | Change vs. last quarter | Period |
|---|---|---|---|---|---|---|
| FidelityFMR | fundamental | 6.28M | $177.54M | 0.01% | Trimmed-1.8% | 2026-03-31 |
| Viking | long/short | 3.65M | $103.21M | 0.29% | Unchanged | 2026-03-31 |
| Wellington | fundamental | 2.12M | $59.86M | 0.01% | Added+11.2% | 2026-03-31 |
| Citadel | multi-strat | 1.01M | $28.45M | 0.04% | Added+41.5% | 2026-03-31 |
| DEShaw | quant | 321.2K | $9.07M | 0.01% | Added+23.3% | 2026-03-31 |
| StateStreet | passive | 152.9K | $4.32M | 0.00% | Trimmed-5.3% | 2026-03-31 |
| TwoSigma | quant | 126.1K | $3.56M | 0.00% | Trimmed-41.4% | 2026-03-31 |
| TRowePrice | fundamental | 442.3K | $12.49K | 0.00% | Trimmed-53.0% | 2026-03-31 |
| Report Date | EPS Estimate | EPS Actual | Surprise |
|---|---|---|---|
| 2026-08-12upcoming | -0.65 | — | — |
| 2026-04-02 | -0.62 | -0.71 | -15.41% |
| 2025-11-12 | -0.67 | -0.60 | +10.71% |
| 2025-08-12 | -0.77 | -0.83 | -8.46% |
| 2025-05-13 | -0.83 | -0.85 | -2.78% |
| 2025-04-07 | -0.73 | -0.64 | +11.91% |
| 2024-11-13 | -0.60 | -0.77 | -27.41% |
| 2024-08-14 | -0.58 | -0.55 | +4.80% |
| 2024-05-08 | -0.57 | -0.52 | +8.77% |
| 2024-04-10 | -0.54 | -0.76 | -40.79% |
| 2023-11-02 | -0.59 | -0.58 | +2.42% |
| 2023-08-07 | -0.58 | -0.63 | -7.75% |
| 2023-05-08 | -0.76 | -0.67 | +11.96% |
| 2023-04-05 | -0.65 | -1.16 | -78.53% |
| 2022-12-08 | -0.63 | -0.25 | +60.61% |
| 2022-09-12 | -0.56 | -0.38 | +32.05% |
| 30d | 90d | YTD | 1y | |
|---|---|---|---|---|
| PHVS | +2.45% | +12.64% | +8.68% | +81.69% |
| XLV | +2.97% | -4.64% | -3.44% | +12.69% |
| Alpha (stock − sector) | -0.52% | +17.28% | +12.13% | +69.00% |